Mucosal immunity in HIV infection: What can be done to restore gastrointestinal-associated lymphoid tissue function?

Current Opinion in Infectious Diseases

Volumn 27, Issue 3, 2014, Pages 275-281

  George, Michael D ^a   Asmuth, David M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

dysbiosis; gut associated lymphoid tissue; HIV enteropathy; microbial translocation

Indexed keywords

CD4 ANTIGEN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

CD4+ T LYMPHOCYTE; DYSBIOSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INTESTINE LYMPHATIC TISSUE; MICROBIAL COMMUNITY; MUCOSAL IMMUNITY; NONHUMAN; POPULATION; REVIEW; DRUG EFFECTS; GALACTOSEMIA; GASTROINTESTINAL TRACT; HELPER CELL; HIV INFECTIONS; IMMUNOLOGY; IMMUNOTHERAPY; INFLAMMATION; INTESTINE MUCOSA; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; PATHOLOGY; PROCEDURES; VIRUS REPLICATION;

ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; GALACTOSEMIAS; GASTROINTESTINAL TRACT; HIV INFECTIONS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOTHERAPY; INFLAMMATION; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; T-LYMPHOCYTES, HELPER-INDUCER; VIRUS REPLICATION;

EID: 84900512579     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000059     Document Type: Review

References (88)

1. Hoyt MJ, Staats JA. Wasting and malnutrition in patients with HIV/AIDS. J Assoc Nurses AIDS Care 1991; 2:16-28.
2. Griffin GE. Malabsorption, malnutrition and HIV disease. Baillieres Clin Gastroenterol 1990; 4:361-373.
3. Kotler DP. Malnutrition in HIV infection and AIDS. AIDS 1989; 3 (Suppl 1): S175-S180.
4. DuPont HL, Marshall GD. HIV-associated diarrhoea and wasting. Lancet 1995; 346:352-356.
5. Cummins AG, LaBrooy JT, Stanley DP, et al. Quantitative histological study of enteropathy associated with HIV infection. Gut 1990; 31:317-321.
6. Ullrich R, Zeitz M, Heise W, et al. Mucosal atrophy is associated with loss of activated T cells in the duodenal mucosa of human immunodeficiency virus (HIV)-infected patients. Digestion 1990; 46 (Suppl 2):302-307.
7. Cramp ME, Hing MC, Marriott DJ, et al. Bile acid malabsorption in HIV infected patients with chronic diarrhoea. Aust N Z J Med 1996; 26:368-371.
8. Ehrenpreis ED, Patterson BK, Brainer JA, et al. Histopathologic findings of duodenal biopsy specimens in HIV-infected patients with and without diarrhea and malabsorption. Am J Clin Pathol 1992; 97:21-28.
9. Lim SG, Condez A, Lee CA, et al. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol 1993; 92:448-454.
10. Kotler DP. HIV infection and the gastrointestinal tract. AIDS 2005; 19:107-117.
11. Siddiqui U, Bini EJ, Chandarana K, et al. Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy. J Clin Gastroenterol 2007; 41:484-490.
12. Mattapallil JJ, Smit-McBride Z, McChesney M, et al. Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4(+) T-cell depletion in primary simian immunodeficiency virus infection. J Virol 1998; 72:6421-6429.
13. Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998; 280:427-431.
14. Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003; 77:11708-11717.
15. Raffatellu M, Santos RL, Verhoeven DE, et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008; 14:421-428.
16. Dandekar S, George MD, Baumler AJ. Th17 cells, HIV and the gut mucosal barrier. Curr Opin HIV AIDS 2010; 5:173-178.
17. Troncone E, Marafini I, Pallone F, Monteleone G. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad. Int Rev Immunol 2013; 32:526-533.
18. Cao AT, Yao S, Gong B, et al. Th17 cells upregulate polymeric Igreceptor and intestinal IgA and contribute to intestinal homeostasis. J Immunol 2012; 189:4666-4673.
19. Zaph C, Du Y, Saenz SA, et al. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 2008; 205:2191-2198.
20. Kim CJ, McKinnon LR, Kovacs C, et al. Mucosal Th17 cell function is altered & during HIV infection and is an independent predictor of systemic immune activation. J Immunol 2013; 191:2164-2173.
21. Ling B, Veazey RS, Hart M, et al. Early restoration of mucosal CD4 memory CCR5 T cells in the gut of SIV-infected rhesus predicts long term nonprogression. AIDS 2007; 21:2377-2385.
22. Sankaran S, Guadalupe M, Reay E, et al. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc Natl Acad Sci U S A 2005; 102:9860-9865.
23. Ciccone EJ, Greenwald JH, Lee PI, et al. CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors. J Virol 2011; 85:5880-5888.
24. Gordon SN, Klatt NR, Bosinger SE, et al. Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J Immunol 2007; 179:3026-3034.
25. Paiardini M, Pandrea I, Apetrei C, Silvestri G. Lessons learned from the natural hosts of HIV-related viruses. Annu Rev Med 2009; 60:485-495.
26. Pandrea IV, Gautam R, Ribeiro RM, et al. Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J Immunol 2007; 179:3035-3046.
27. Paiardini M, Frank I, Pandrea I, et al. Mucosal immune dysfunction in AIDS pathogenesis. AIDS Rev 2008; 10:36-46.
28. Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43: 27-34.
29. Macal M, Sankaran S, Chun TW, et al. Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol 2008; 1:475-488.
30. Hayes TL, Asmuth DM, Critchfield JW, et al. Impact of highly active antire-troviral therapy initiation on CD4(+) T-cell repopulation in duodenal and rectal mucosa. AIDS 2013; 27:867-877.
31. Karris MY, Kao YT, Patel D, et al. Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection. AIDS 2014;28:841-849.
32. Tugizov SM, Herrera R, Chin-Hong P, et al. HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papilloma virus. Virology 2013; 446:378-388.
33. Buccigrossi V, Laudiero G, Nicastro E, et al. The HIV-1 transactivator factor (Tat) induces enterocyte apoptosis through a redox-mediated mechanism. PLoS One 2011; 6:e29436.
34. Guadalupe M, Sankaran S, George MD, et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol 2006; 80:8236-8247.
35. Lederman MM, Funderburg NT, Sekaly RP, et al. Residual immune dysregulation syndrome in treated HIV infection. Adv Immunol 2013; 119:51-83.
36. Yukl SA, Shergill AK, Ho T, et al. The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence. J Infect Dis 2013; 208:1212-1220.
37. Hatano H, Somsouk M, Sinclair E, et al. Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers. AIDS 2013; 27:2255-2260.
38. Eisele E, Siliciano RF. Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity 2012; 37:377-388.
39. Rueda CM, Velilla PA, Chougnet CA, et al. HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment. PLoS One 2012; 7:e30307.
40. + T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest 2012; 122:62-69.
41. Estes J, Baker JV, Brenchley JM, et al. Collagen deposition limits immune reconstitution in the gut. J Infect Dis 2008; 198:456-464.
42. Asmuth DM, Ma ZM, Mann S, et al. Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus nonnucleoside reverse transcriptase inhibitor-based regimens. AIDS 2012; 26:1625-1634.
43. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
44. Redd AD, Dabitao D, Bream JH, et al. Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci USA 2009; 106:6718-6723.
45. Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009; 199:1177-1185.
46. Ancuta P, Kamat A, Kunstman KJ, et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 2008; 3:e2516.
47. Marks MA, Rabkin CS, Engels EA, et al. Markers of microbial translocation and risk of AIDS-related lymphoma. AIDS 2013; 27:469-474.
48. Abad-Fernandez M, Vallejo A, Hernandez-Novoa B, et al. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals. J Acquir Immune Defic Syndr 2013; 64:149-153.
49. Pilakka-Kanthikeel S, Arheart K, Selvaraj A, et al. Immune activation is associated with increased gut microbial translocation in treatment naive HIV infected children in a resource limited setting. J Acquir Immune Defic Syndr 2013. [Epub ahead of print]
50. Fitzgerald F, Harris K, Doyle R, et al. Short communication: evidence that microbial translocation occurs in HIV-infected children in the United Kingdom. AIDS Res Hum Retroviruses 2013; 29:1589-1593.
51. Troseid M, Sonnerborg A, Nowak P. High mobility group box protein-1 in HIV-1 infection. Curr HIV Res 2011; 9:6-10.
52. Mureith MW, Chang JJ, Lifson JD, et al. Exposure to HIV-1-encoded Toll-like receptor 8 ligands enhances monocyte response to microbial encoded Tolllike receptor 2/4 ligands. AIDS 2010; 24:1841-1848.
53. Deeks SG, Kitchen CM, Liu L, et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004; 104:942-947.
54. Torres RA, Lewis W. Aging and HIV/AIDS: pathogenetic role of therapeutic side effects. Lab Invest 2014; 94:120-128.
55. Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity 2013; 39:633-645.
56. Marchetti G, Nasta P, Bai F, et al. Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients. PLoS One 2012; 7:e32028.
57. French AL, Evans CT, Agniel DM, et al. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus. J Infect Dis 2013; 208:679-689.
58. Hudson CL, Zemlin AE, Ipp H. The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression. Ann Clin Biochem 2013. [Epub ahead of print]
59. Merlini E, Luzi K, Suardi E, et al. T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis. PLoS One 2012; 7:e46073.
60. Lyons JL, Uno H, Ancuta P, et al. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr 2011; 57:371-379.
61. Erlandson KM, Allshouse AA, Jankowski CM, et al. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis 2013; 208:249-259.
62. Reus S, Portilla J, Sanchez-Paya J, et al. Low-level HIV viremia is associated with microbial translocation and inflammation. J Acquir Immune Defic Syndr 2013; 62:129-134.
63. + T cells decreases after prolonged antiretroviral therapy and is associated with plasma LPS levels. Mucosal Immunol 2010; 3:172-181.
64. + T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 2008; 22:2035-2038.
65. Marchetti G, Tincati C, Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev 2013; 26:2-18.
66. + T cells regulate IL-22-producing intestinal innate lymphoid cells. Mucosal Immunol 2014. [Epub ahead of print]
67. Slack E, Hapfelmeier S, Stecher B, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009; 325:617-620.
68. Jiang W. Microbial translocation and B cell dysfunction in human immunodeficiency virus disease. Am J Immunol 2012; 8:44-51.
69. Erikstrup C, Kronborg G, Lohse N, et al. T-cell dysfunction in HIV-1-infected patients with impaired recovery of CD4 cells despite suppression of viral replication. J Acquir Immune Defic Syndr 2010; 53:303-310.
70. Gori A, Tincati C, Rizzardini G, et al. Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J Clin Microbiol 2008; 46:757-758.
71. Ellis CL, Ma ZM, Mann SK, et al. Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. J Acquir Immune Defic Syndr 2011; 57:363-370.
72. Lozupone CA, Li M, Campbell TB, et al. Alterations in the gut microbiota & associated with HIV-1 infection. Cell Host Microbe 2013; 14:329-339.
73. Vujkovic-Cvijin I, Dunham RM, Iwai S, et al. Dysbiosis of the gut microbiota is & associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 2013; 5:193ra191.
74. Dillon SM, Lee EJ, Kotter CV, et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol 2014. [Epub ahead of print]
75. Olivares M, Laparra JM, Sanz Y. Host genotype, intestinal microbiota and inflammatory disorders. Br J Nutr 2013; 109 (Suppl 2):S76-S80.
76. McKnite AM, Perez-Munoz ME, Lu L, et al. Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits. PLoS One 2012; 7:e39191.
77. Rothe M, Blaut M. Evolution of the gut microbiota and the influence of diet. Benef Microbes 2013; 4:31-37.
78. Scott KP, Gratz SW, Sheridan PO, et al. The influence of diet on the gut microbiota. Pharmacol Res 2013; 69:52-60.
79. Mukherji A, Kobiita A, Ye T, Chambon P. Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell 2013; 153:812-827.
80. Henao-Mejia J, Strowig T, Flavell RA. Microbiota keep the intestinal clock ticking. Cell 2013; 153:741-743.
81. Perez-Bosque A, Miro L, Polo J, et al. Dietary plasma proteins modulate the immune response of diffuse gut-associated lymphoid tissue in rats challenged with Staphylococcus aureus enterotoxin B. J Nutr 2008; 138:533-537.
82. Perez-Bosque A, Miro L, Polo J, et al. Dietary plasma protein supplements prevent the release of mucosal proinflammatory mediators in intestinal inflammation in rats. J Nutr 2010; 140:25-30.
83. Asmuth DM, Ma ZM, Albanese A, et al. Oral serum-derived bovine immuno-globulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy. AIDS 2013; 27:2207-2217.
84. Sugimoto K, Ogawa A, Mizoguchi E, et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008; 118:534-544.
85. Dyavar Shetty R, Velu V, et al. PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques. J Clin Invest 2012; 122:1712-1716.
86. Klatt NR, Canary LA, Sun X, et al. Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. J Clin Invest 2013; 123:903-907.
87. Irvine SL, Hummelen R, Hekmat S. Probiotic yogurt consumption may improve gastrointestinal symptoms, productivity, and nutritional intake of people living with human immunodeficiency virus in Mwanza, Tanzania. Nutr Res 2011; 31:875-881.
88. Perez-Santiago J, Gianella S, Massanella M, et al. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection. AIDS 2013; 27:1921-1931.